Tata India Pharma & Healthcare Fund
Empty
1–7 yearsInvestment Horizon
Empty
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation20.3%
Sharpe Ratio0.47
Beta1.05
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices11.17%
Cash / Net Current AssetUtilities7.36%
Apollo Hospitals Enterprise LtdServices7.19%
Cipla LtdServices5.76%
Divi's Laboratories LtdServices5.58%
Aurobindo Pharma LtdServices5.44%
Fortis Healthcare LtdServices5.30%
Lupin LtdServices4.58%
Aster DM Healthcare Ltd Ordinary SharesServices4.45%
Wockhardt LtdServices3.67%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.11%
Exit Load0.25
Regulatory & Tax Information
INF277K016A9
ISINDailyDealing Frequency
BSE Healthcare PRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)